Sanofi CEO warns of short-term vaccine demand weakness in US due to misinformation and administration scrutiny.

Wednesday, Jan 14, 2026 2:27 pm ET1min read
SNY--

Sanofi's CEO, Paul Hudson, expects a slight weakness in US vaccine demand this year due to misinformation and heightened scrutiny under the current administration. The company reported a decline in vaccine sales in Q3 and expects demand to stabilize over time. Hudson believes that policy uncertainty has created favorable conditions for vaccine-focused M&A. Combined flu-COVID vaccines could drive the next wave of vaccine uptake from 2027 or 2028, particularly among older adults.

Sanofi CEO warns of short-term vaccine demand weakness in US due to misinformation and administration scrutiny.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet